Related Experiment Video
Updated: Sep 3, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Extracellular vesicles in pancreatic cancer immune escape: Emerging roles and mechanisms
Chunping Liu1, Dongyue He2, Longmei Li2
1State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Abstract:
Pancreatic cancer (PC) is the most lethal malignancy worldwide due to its delayed diagnosis and limited treatment options. Despite great progress in clinical trials of immunotherapies for various cancers, their effectiveness in PC is very low, indicating that immune evasion is still a major obstacle to immunotherapy in PC. However, the mechanism of immune escape in PC is not fully understood, which substantially restricts the development of immunotherapy. As an important component of intercellular communication networks, extracellular vesicles (EVs) have attracted increasing attention in relation to immune escape. This review aims to provide a better understanding of the roles of EVs in tumor immune escape and the potential to expand their application in cancer immunotherapy. The relationship between PC and the tumor immune microenvironment is briefly introduced. Then, the mechanism by which EVs are involved in immune regulation is summarized, and the latest progress in determining the role of EVs in regulating PC immune escape is highlighted.
Insights
Pancreatic cancer (PC) evades immune attack, hindering immunotherapy. Extracellular vesicles (EVs) play a key role in this immune escape, offering potential new therapeutic strategies for PC treatment.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Pancreatic cancer (PC) is a highly lethal malignancy with limited treatment options.
- Current immunotherapies show low effectiveness in PC, primarily due to immune evasion.
- Understanding the mechanisms of immune escape is crucial for advancing PC immunotherapy.
Purpose of the Study:
- To review the role of extracellular vesicles (EVs) in tumor immune escape.
- To elucidate the mechanisms by which EVs regulate immune responses in the context of PC.
- To highlight the potential of EVs in overcoming immune evasion for improved PC immunotherapy.
Main Methods:
- Literature review focusing on pancreatic cancer, tumor immunology, and extracellular vesicles.
- Summary of intercellular communication networks involving EVs.
- Analysis of the latest research on EVs in regulating PC immune escape.
Main Results:
- Extracellular vesicles (EVs) are significant mediators of intercellular communication.
- EVs play a critical role in regulating the tumor immune microenvironment and promoting immune escape in PC.
- Specific mechanisms of EV-mediated immune regulation in PC are being elucidated.
Conclusions:
- Extracellular vesicles (EVs) are key players in pancreatic cancer's immune evasion strategies.
- Targeting EV-mediated immune suppression presents a promising avenue for novel PC immunotherapies.
- Further research into EVs could unlock new therapeutic applications for pancreatic cancer.
More Related Videos
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
06:21Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
Related Concept Videos
Cancer Cell Migration through Invadopodia
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Insulin Secretory Vesicles
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...